Global Biological Hemostatic Material Supply, Demand and Key Producers, 2023-2029
The global Biological Hemostatic Material market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Biological hemostatic agents are active agents that work to provide hemostasis by activating clotting factors in the final stages of the coagulation cascade. Thrombin is activated by calcium and as noted previously acts to convert fibrinogen to fibrin, stabilizing the clot.
This report studies the global Biological Hemostatic Material production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Biological Hemostatic Material, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biological Hemostatic Material that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Biological Hemostatic Material total production and demand, 2018-2029, (K Units)
Global Biological Hemostatic Material total production value, 2018-2029, (USD Million)
Global Biological Hemostatic Material production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Biological Hemostatic Material consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Biological Hemostatic Material domestic production, consumption, key domestic manufacturers and share
Global Biological Hemostatic Material production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Biological Hemostatic Material production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Biological Hemostatic Material production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Biological Hemostatic Material market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson & Johnson, BD, Baxter, B.Braun, Cura Medical, GELITA MEDICAL, Curasan AG, Meril Life Sciences and Zhonghui Shengxi, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Biological Hemostatic Material market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Biological Hemostatic Material Market, By Region:
1. How big is the global Biological Hemostatic Material market?
2. What is the demand of the global Biological Hemostatic Material market?
3. What is the year over year growth of the global Biological Hemostatic Material market?
4. What is the production and production value of the global Biological Hemostatic Material market?
5. Who are the key producers in the global Biological Hemostatic Material market?
6. What are the growth factors driving the market demand?
Biological hemostatic agents are active agents that work to provide hemostasis by activating clotting factors in the final stages of the coagulation cascade. Thrombin is activated by calcium and as noted previously acts to convert fibrinogen to fibrin, stabilizing the clot.
This report studies the global Biological Hemostatic Material production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Biological Hemostatic Material, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biological Hemostatic Material that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Biological Hemostatic Material total production and demand, 2018-2029, (K Units)
Global Biological Hemostatic Material total production value, 2018-2029, (USD Million)
Global Biological Hemostatic Material production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Biological Hemostatic Material consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Biological Hemostatic Material domestic production, consumption, key domestic manufacturers and share
Global Biological Hemostatic Material production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Biological Hemostatic Material production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Biological Hemostatic Material production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Biological Hemostatic Material market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Johnson & Johnson, BD, Baxter, B.Braun, Cura Medical, GELITA MEDICAL, Curasan AG, Meril Life Sciences and Zhonghui Shengxi, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Biological Hemostatic Material market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Biological Hemostatic Material Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Collagen
- Gelatin
- Polysaccharides
- Other
- Hospital
- Clinic
- Other
- Johnson & Johnson
- BD
- Baxter
- B.Braun
- Cura Medical
- GELITA MEDICAL
- Curasan AG
- Meril Life Sciences
- Zhonghui Shengxi
- Beijing Datsing Bio-tech
- Guizhou Jin Jiu Biotech
- Beijing Taikesiman
- Foryou Medical
- Saikesaisi Holdings Group
- Biotemed
- Hangzhou Singclean Medical Products
1. How big is the global Biological Hemostatic Material market?
2. What is the demand of the global Biological Hemostatic Material market?
3. What is the year over year growth of the global Biological Hemostatic Material market?
4. What is the production and production value of the global Biological Hemostatic Material market?
5. Who are the key producers in the global Biological Hemostatic Material market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Biological Hemostatic Material Introduction
1.2 World Biological Hemostatic Material Supply & Forecast
1.2.1 World Biological Hemostatic Material Production Value (2018 & 2022 & 2029)
1.2.2 World Biological Hemostatic Material Production (2018-2029)
1.2.3 World Biological Hemostatic Material Pricing Trends (2018-2029)
1.3 World Biological Hemostatic Material Production by Region (Based on Production Site)
1.3.1 World Biological Hemostatic Material Production Value by Region (2018-2029)
1.3.2 World Biological Hemostatic Material Production by Region (2018-2029)
1.3.3 World Biological Hemostatic Material Average Price by Region (2018-2029)
1.3.4 North America Biological Hemostatic Material Production (2018-2029)
1.3.5 Europe Biological Hemostatic Material Production (2018-2029)
1.3.6 China Biological Hemostatic Material Production (2018-2029)
1.3.7 Japan Biological Hemostatic Material Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Biological Hemostatic Material Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Biological Hemostatic Material Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Biological Hemostatic Material Demand (2018-2029)
2.2 World Biological Hemostatic Material Consumption by Region
2.2.1 World Biological Hemostatic Material Consumption by Region (2018-2023)
2.2.2 World Biological Hemostatic Material Consumption Forecast by Region (2024-2029)
2.3 United States Biological Hemostatic Material Consumption (2018-2029)
2.4 China Biological Hemostatic Material Consumption (2018-2029)
2.5 Europe Biological Hemostatic Material Consumption (2018-2029)
2.6 Japan Biological Hemostatic Material Consumption (2018-2029)
2.7 South Korea Biological Hemostatic Material Consumption (2018-2029)
2.8 ASEAN Biological Hemostatic Material Consumption (2018-2029)
2.9 India Biological Hemostatic Material Consumption (2018-2029)
3 WORLD BIOLOGICAL HEMOSTATIC MATERIAL MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Biological Hemostatic Material Production Value by Manufacturer (2018-2023)
3.2 World Biological Hemostatic Material Production by Manufacturer (2018-2023)
3.3 World Biological Hemostatic Material Average Price by Manufacturer (2018-2023)
3.4 Biological Hemostatic Material Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Biological Hemostatic Material Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Biological Hemostatic Material in 2022
3.5.3 Global Concentration Ratios (CR8) for Biological Hemostatic Material in 2022
3.6 Biological Hemostatic Material Market: Overall Company Footprint Analysis
3.6.1 Biological Hemostatic Material Market: Region Footprint
3.6.2 Biological Hemostatic Material Market: Company Product Type Footprint
3.6.3 Biological Hemostatic Material Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Biological Hemostatic Material Production Value Comparison
4.1.1 United States VS China: Biological Hemostatic Material Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Biological Hemostatic Material Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Biological Hemostatic Material Production Comparison
4.2.1 United States VS China: Biological Hemostatic Material Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Biological Hemostatic Material Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Biological Hemostatic Material Consumption Comparison
4.3.1 United States VS China: Biological Hemostatic Material Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Biological Hemostatic Material Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Biological Hemostatic Material Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Biological Hemostatic Material Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Biological Hemostatic Material Production Value (2018-2023)
4.4.3 United States Based Manufacturers Biological Hemostatic Material Production (2018-2023)
4.5 China Based Biological Hemostatic Material Manufacturers and Market Share
4.5.1 China Based Biological Hemostatic Material Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Biological Hemostatic Material Production Value (2018-2023)
4.5.3 China Based Manufacturers Biological Hemostatic Material Production (2018-2023)
4.6 Rest of World Based Biological Hemostatic Material Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Biological Hemostatic Material Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Biological Hemostatic Material Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Biological Hemostatic Material Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Biological Hemostatic Material Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Collagen
5.2.2 Gelatin
5.2.3 Polysaccharides
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World Biological Hemostatic Material Production by Type (2018-2029)
5.3.2 World Biological Hemostatic Material Production Value by Type (2018-2029)
5.3.3 World Biological Hemostatic Material Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Biological Hemostatic Material Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Biological Hemostatic Material Production by Application (2018-2029)
6.3.2 World Biological Hemostatic Material Production Value by Application (2018-2029)
6.3.3 World Biological Hemostatic Material Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Details
7.1.2 Johnson & Johnson Major Business
7.1.3 Johnson & Johnson Biological Hemostatic Material Product and Services
7.1.4 Johnson & Johnson Biological Hemostatic Material Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Johnson & Johnson Recent Developments/Updates
7.1.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.2 BD
7.2.1 BD Details
7.2.2 BD Major Business
7.2.3 BD Biological Hemostatic Material Product and Services
7.2.4 BD Biological Hemostatic Material Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 BD Recent Developments/Updates
7.2.6 BD Competitive Strengths & Weaknesses
7.3 Baxter
7.3.1 Baxter Details
7.3.2 Baxter Major Business
7.3.3 Baxter Biological Hemostatic Material Product and Services
7.3.4 Baxter Biological Hemostatic Material Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Baxter Recent Developments/Updates
7.3.6 Baxter Competitive Strengths & Weaknesses
7.4 B.Braun
7.4.1 B.Braun Details
7.4.2 B.Braun Major Business
7.4.3 B.Braun Biological Hemostatic Material Product and Services
7.4.4 B.Braun Biological Hemostatic Material Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 B.Braun Recent Developments/Updates
7.4.6 B.Braun Competitive Strengths & Weaknesses
7.5 Cura Medical
7.5.1 Cura Medical Details
7.5.2 Cura Medical Major Business
7.5.3 Cura Medical Biological Hemostatic Material Product and Services
7.5.4 Cura Medical Biological Hemostatic Material Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Cura Medical Recent Developments/Updates
7.5.6 Cura Medical Competitive Strengths & Weaknesses
7.6 GELITA MEDICAL
7.6.1 GELITA MEDICAL Details
7.6.2 GELITA MEDICAL Major Business
7.6.3 GELITA MEDICAL Biological Hemostatic Material Product and Services
7.6.4 GELITA MEDICAL Biological Hemostatic Material Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 GELITA MEDICAL Recent Developments/Updates
7.6.6 GELITA MEDICAL Competitive Strengths & Weaknesses
7.7 Curasan AG
7.7.1 Curasan AG Details
7.7.2 Curasan AG Major Business
7.7.3 Curasan AG Biological Hemostatic Material Product and Services
7.7.4 Curasan AG Biological Hemostatic Material Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Curasan AG Recent Developments/Updates
7.7.6 Curasan AG Competitive Strengths & Weaknesses
7.8 Meril Life Sciences
7.8.1 Meril Life Sciences Details
7.8.2 Meril Life Sciences Major Business
7.8.3 Meril Life Sciences Biological Hemostatic Material Product and Services
7.8.4 Meril Life Sciences Biological Hemostatic Material Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Meril Life Sciences Recent Developments/Updates
7.8.6 Meril Life Sciences Competitive Strengths & Weaknesses
7.9 Zhonghui Shengxi
7.9.1 Zhonghui Shengxi Details
7.9.2 Zhonghui Shengxi Major Business
7.9.3 Zhonghui Shengxi Biological Hemostatic Material Product and Services
7.9.4 Zhonghui Shengxi Biological Hemostatic Material Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Zhonghui Shengxi Recent Developments/Updates
7.9.6 Zhonghui Shengxi Competitive Strengths & Weaknesses
7.10 Beijing Datsing Bio-tech
7.10.1 Beijing Datsing Bio-tech Details
7.10.2 Beijing Datsing Bio-tech Major Business
7.10.3 Beijing Datsing Bio-tech Biological Hemostatic Material Product and Services
7.10.4 Beijing Datsing Bio-tech Biological Hemostatic Material Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Beijing Datsing Bio-tech Recent Developments/Updates
7.10.6 Beijing Datsing Bio-tech Competitive Strengths & Weaknesses
7.11 Guizhou Jin Jiu Biotech
7.11.1 Guizhou Jin Jiu Biotech Details
7.11.2 Guizhou Jin Jiu Biotech Major Business
7.11.3 Guizhou Jin Jiu Biotech Biological Hemostatic Material Product and Services
7.11.4 Guizhou Jin Jiu Biotech Biological Hemostatic Material Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Guizhou Jin Jiu Biotech Recent Developments/Updates
7.11.6 Guizhou Jin Jiu Biotech Competitive Strengths & Weaknesses
7.12 Beijing Taikesiman
7.12.1 Beijing Taikesiman Details
7.12.2 Beijing Taikesiman Major Business
7.12.3 Beijing Taikesiman Biological Hemostatic Material Product and Services
7.12.4 Beijing Taikesiman Biological Hemostatic Material Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Beijing Taikesiman Recent Developments/Updates
7.12.6 Beijing Taikesiman Competitive Strengths & Weaknesses
7.13 Foryou Medical
7.13.1 Foryou Medical Details
7.13.2 Foryou Medical Major Business
7.13.3 Foryou Medical Biological Hemostatic Material Product and Services
7.13.4 Foryou Medical Biological Hemostatic Material Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Foryou Medical Recent Developments/Updates
7.13.6 Foryou Medical Competitive Strengths & Weaknesses
7.14 Saikesaisi Holdings Group
7.14.1 Saikesaisi Holdings Group Details
7.14.2 Saikesaisi Holdings Group Major Business
7.14.3 Saikesaisi Holdings Group Biological Hemostatic Material Product and Services
7.14.4 Saikesaisi Holdings Group Biological Hemostatic Material Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Saikesaisi Holdings Group Recent Developments/Updates
7.14.6 Saikesaisi Holdings Group Competitive Strengths & Weaknesses
7.15 Biotemed
7.15.1 Biotemed Details
7.15.2 Biotemed Major Business
7.15.3 Biotemed Biological Hemostatic Material Product and Services
7.15.4 Biotemed Biological Hemostatic Material Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Biotemed Recent Developments/Updates
7.15.6 Biotemed Competitive Strengths & Weaknesses
7.16 Hangzhou Singclean Medical Products
7.16.1 Hangzhou Singclean Medical Products Details
7.16.2 Hangzhou Singclean Medical Products Major Business
7.16.3 Hangzhou Singclean Medical Products Biological Hemostatic Material Product and Services
7.16.4 Hangzhou Singclean Medical Products Biological Hemostatic Material Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Hangzhou Singclean Medical Products Recent Developments/Updates
7.16.6 Hangzhou Singclean Medical Products Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Biological Hemostatic Material Industry Chain
8.2 Biological Hemostatic Material Upstream Analysis
8.2.1 Biological Hemostatic Material Core Raw Materials
8.2.2 Main Manufacturers of Biological Hemostatic Material Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Biological Hemostatic Material Production Mode
8.6 Biological Hemostatic Material Procurement Model
8.7 Biological Hemostatic Material Industry Sales Model and Sales Channels
8.7.1 Biological Hemostatic Material Sales Model
8.7.2 Biological Hemostatic Material Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Biological Hemostatic Material Introduction
1.2 World Biological Hemostatic Material Supply & Forecast
1.2.1 World Biological Hemostatic Material Production Value (2018 & 2022 & 2029)
1.2.2 World Biological Hemostatic Material Production (2018-2029)
1.2.3 World Biological Hemostatic Material Pricing Trends (2018-2029)
1.3 World Biological Hemostatic Material Production by Region (Based on Production Site)
1.3.1 World Biological Hemostatic Material Production Value by Region (2018-2029)
1.3.2 World Biological Hemostatic Material Production by Region (2018-2029)
1.3.3 World Biological Hemostatic Material Average Price by Region (2018-2029)
1.3.4 North America Biological Hemostatic Material Production (2018-2029)
1.3.5 Europe Biological Hemostatic Material Production (2018-2029)
1.3.6 China Biological Hemostatic Material Production (2018-2029)
1.3.7 Japan Biological Hemostatic Material Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Biological Hemostatic Material Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Biological Hemostatic Material Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Biological Hemostatic Material Demand (2018-2029)
2.2 World Biological Hemostatic Material Consumption by Region
2.2.1 World Biological Hemostatic Material Consumption by Region (2018-2023)
2.2.2 World Biological Hemostatic Material Consumption Forecast by Region (2024-2029)
2.3 United States Biological Hemostatic Material Consumption (2018-2029)
2.4 China Biological Hemostatic Material Consumption (2018-2029)
2.5 Europe Biological Hemostatic Material Consumption (2018-2029)
2.6 Japan Biological Hemostatic Material Consumption (2018-2029)
2.7 South Korea Biological Hemostatic Material Consumption (2018-2029)
2.8 ASEAN Biological Hemostatic Material Consumption (2018-2029)
2.9 India Biological Hemostatic Material Consumption (2018-2029)
3 WORLD BIOLOGICAL HEMOSTATIC MATERIAL MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Biological Hemostatic Material Production Value by Manufacturer (2018-2023)
3.2 World Biological Hemostatic Material Production by Manufacturer (2018-2023)
3.3 World Biological Hemostatic Material Average Price by Manufacturer (2018-2023)
3.4 Biological Hemostatic Material Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Biological Hemostatic Material Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Biological Hemostatic Material in 2022
3.5.3 Global Concentration Ratios (CR8) for Biological Hemostatic Material in 2022
3.6 Biological Hemostatic Material Market: Overall Company Footprint Analysis
3.6.1 Biological Hemostatic Material Market: Region Footprint
3.6.2 Biological Hemostatic Material Market: Company Product Type Footprint
3.6.3 Biological Hemostatic Material Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Biological Hemostatic Material Production Value Comparison
4.1.1 United States VS China: Biological Hemostatic Material Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Biological Hemostatic Material Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Biological Hemostatic Material Production Comparison
4.2.1 United States VS China: Biological Hemostatic Material Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Biological Hemostatic Material Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Biological Hemostatic Material Consumption Comparison
4.3.1 United States VS China: Biological Hemostatic Material Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Biological Hemostatic Material Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Biological Hemostatic Material Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Biological Hemostatic Material Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Biological Hemostatic Material Production Value (2018-2023)
4.4.3 United States Based Manufacturers Biological Hemostatic Material Production (2018-2023)
4.5 China Based Biological Hemostatic Material Manufacturers and Market Share
4.5.1 China Based Biological Hemostatic Material Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Biological Hemostatic Material Production Value (2018-2023)
4.5.3 China Based Manufacturers Biological Hemostatic Material Production (2018-2023)
4.6 Rest of World Based Biological Hemostatic Material Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Biological Hemostatic Material Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Biological Hemostatic Material Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Biological Hemostatic Material Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Biological Hemostatic Material Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Collagen
5.2.2 Gelatin
5.2.3 Polysaccharides
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World Biological Hemostatic Material Production by Type (2018-2029)
5.3.2 World Biological Hemostatic Material Production Value by Type (2018-2029)
5.3.3 World Biological Hemostatic Material Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Biological Hemostatic Material Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World Biological Hemostatic Material Production by Application (2018-2029)
6.3.2 World Biological Hemostatic Material Production Value by Application (2018-2029)
6.3.3 World Biological Hemostatic Material Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Details
7.1.2 Johnson & Johnson Major Business
7.1.3 Johnson & Johnson Biological Hemostatic Material Product and Services
7.1.4 Johnson & Johnson Biological Hemostatic Material Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Johnson & Johnson Recent Developments/Updates
7.1.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.2 BD
7.2.1 BD Details
7.2.2 BD Major Business
7.2.3 BD Biological Hemostatic Material Product and Services
7.2.4 BD Biological Hemostatic Material Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 BD Recent Developments/Updates
7.2.6 BD Competitive Strengths & Weaknesses
7.3 Baxter
7.3.1 Baxter Details
7.3.2 Baxter Major Business
7.3.3 Baxter Biological Hemostatic Material Product and Services
7.3.4 Baxter Biological Hemostatic Material Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Baxter Recent Developments/Updates
7.3.6 Baxter Competitive Strengths & Weaknesses
7.4 B.Braun
7.4.1 B.Braun Details
7.4.2 B.Braun Major Business
7.4.3 B.Braun Biological Hemostatic Material Product and Services
7.4.4 B.Braun Biological Hemostatic Material Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 B.Braun Recent Developments/Updates
7.4.6 B.Braun Competitive Strengths & Weaknesses
7.5 Cura Medical
7.5.1 Cura Medical Details
7.5.2 Cura Medical Major Business
7.5.3 Cura Medical Biological Hemostatic Material Product and Services
7.5.4 Cura Medical Biological Hemostatic Material Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Cura Medical Recent Developments/Updates
7.5.6 Cura Medical Competitive Strengths & Weaknesses
7.6 GELITA MEDICAL
7.6.1 GELITA MEDICAL Details
7.6.2 GELITA MEDICAL Major Business
7.6.3 GELITA MEDICAL Biological Hemostatic Material Product and Services
7.6.4 GELITA MEDICAL Biological Hemostatic Material Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 GELITA MEDICAL Recent Developments/Updates
7.6.6 GELITA MEDICAL Competitive Strengths & Weaknesses
7.7 Curasan AG
7.7.1 Curasan AG Details
7.7.2 Curasan AG Major Business
7.7.3 Curasan AG Biological Hemostatic Material Product and Services
7.7.4 Curasan AG Biological Hemostatic Material Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Curasan AG Recent Developments/Updates
7.7.6 Curasan AG Competitive Strengths & Weaknesses
7.8 Meril Life Sciences
7.8.1 Meril Life Sciences Details
7.8.2 Meril Life Sciences Major Business
7.8.3 Meril Life Sciences Biological Hemostatic Material Product and Services
7.8.4 Meril Life Sciences Biological Hemostatic Material Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Meril Life Sciences Recent Developments/Updates
7.8.6 Meril Life Sciences Competitive Strengths & Weaknesses
7.9 Zhonghui Shengxi
7.9.1 Zhonghui Shengxi Details
7.9.2 Zhonghui Shengxi Major Business
7.9.3 Zhonghui Shengxi Biological Hemostatic Material Product and Services
7.9.4 Zhonghui Shengxi Biological Hemostatic Material Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Zhonghui Shengxi Recent Developments/Updates
7.9.6 Zhonghui Shengxi Competitive Strengths & Weaknesses
7.10 Beijing Datsing Bio-tech
7.10.1 Beijing Datsing Bio-tech Details
7.10.2 Beijing Datsing Bio-tech Major Business
7.10.3 Beijing Datsing Bio-tech Biological Hemostatic Material Product and Services
7.10.4 Beijing Datsing Bio-tech Biological Hemostatic Material Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Beijing Datsing Bio-tech Recent Developments/Updates
7.10.6 Beijing Datsing Bio-tech Competitive Strengths & Weaknesses
7.11 Guizhou Jin Jiu Biotech
7.11.1 Guizhou Jin Jiu Biotech Details
7.11.2 Guizhou Jin Jiu Biotech Major Business
7.11.3 Guizhou Jin Jiu Biotech Biological Hemostatic Material Product and Services
7.11.4 Guizhou Jin Jiu Biotech Biological Hemostatic Material Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Guizhou Jin Jiu Biotech Recent Developments/Updates
7.11.6 Guizhou Jin Jiu Biotech Competitive Strengths & Weaknesses
7.12 Beijing Taikesiman
7.12.1 Beijing Taikesiman Details
7.12.2 Beijing Taikesiman Major Business
7.12.3 Beijing Taikesiman Biological Hemostatic Material Product and Services
7.12.4 Beijing Taikesiman Biological Hemostatic Material Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Beijing Taikesiman Recent Developments/Updates
7.12.6 Beijing Taikesiman Competitive Strengths & Weaknesses
7.13 Foryou Medical
7.13.1 Foryou Medical Details
7.13.2 Foryou Medical Major Business
7.13.3 Foryou Medical Biological Hemostatic Material Product and Services
7.13.4 Foryou Medical Biological Hemostatic Material Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Foryou Medical Recent Developments/Updates
7.13.6 Foryou Medical Competitive Strengths & Weaknesses
7.14 Saikesaisi Holdings Group
7.14.1 Saikesaisi Holdings Group Details
7.14.2 Saikesaisi Holdings Group Major Business
7.14.3 Saikesaisi Holdings Group Biological Hemostatic Material Product and Services
7.14.4 Saikesaisi Holdings Group Biological Hemostatic Material Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Saikesaisi Holdings Group Recent Developments/Updates
7.14.6 Saikesaisi Holdings Group Competitive Strengths & Weaknesses
7.15 Biotemed
7.15.1 Biotemed Details
7.15.2 Biotemed Major Business
7.15.3 Biotemed Biological Hemostatic Material Product and Services
7.15.4 Biotemed Biological Hemostatic Material Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Biotemed Recent Developments/Updates
7.15.6 Biotemed Competitive Strengths & Weaknesses
7.16 Hangzhou Singclean Medical Products
7.16.1 Hangzhou Singclean Medical Products Details
7.16.2 Hangzhou Singclean Medical Products Major Business
7.16.3 Hangzhou Singclean Medical Products Biological Hemostatic Material Product and Services
7.16.4 Hangzhou Singclean Medical Products Biological Hemostatic Material Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Hangzhou Singclean Medical Products Recent Developments/Updates
7.16.6 Hangzhou Singclean Medical Products Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Biological Hemostatic Material Industry Chain
8.2 Biological Hemostatic Material Upstream Analysis
8.2.1 Biological Hemostatic Material Core Raw Materials
8.2.2 Main Manufacturers of Biological Hemostatic Material Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Biological Hemostatic Material Production Mode
8.6 Biological Hemostatic Material Procurement Model
8.7 Biological Hemostatic Material Industry Sales Model and Sales Channels
8.7.1 Biological Hemostatic Material Sales Model
8.7.2 Biological Hemostatic Material Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Biological Hemostatic Material Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Biological Hemostatic Material Production Value by Region (2018-2023) & (USD Million)
Table 3. World Biological Hemostatic Material Production Value by Region (2024-2029) & (USD Million)
Table 4. World Biological Hemostatic Material Production Value Market Share by Region (2018-2023)
Table 5. World Biological Hemostatic Material Production Value Market Share by Region (2024-2029)
Table 6. World Biological Hemostatic Material Production by Region (2018-2023) & (K Units)
Table 7. World Biological Hemostatic Material Production by Region (2024-2029) & (K Units)
Table 8. World Biological Hemostatic Material Production Market Share by Region (2018-2023)
Table 9. World Biological Hemostatic Material Production Market Share by Region (2024-2029)
Table 10. World Biological Hemostatic Material Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Biological Hemostatic Material Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Biological Hemostatic Material Major Market Trends
Table 13. World Biological Hemostatic Material Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Biological Hemostatic Material Consumption by Region (2018-2023) & (K Units)
Table 15. World Biological Hemostatic Material Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Biological Hemostatic Material Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Biological Hemostatic Material Producers in 2022
Table 18. World Biological Hemostatic Material Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Biological Hemostatic Material Producers in 2022
Table 20. World Biological Hemostatic Material Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Biological Hemostatic Material Company Evaluation Quadrant
Table 22. World Biological Hemostatic Material Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Biological Hemostatic Material Production Site of Key Manufacturer
Table 24. Biological Hemostatic Material Market: Company Product Type Footprint
Table 25. Biological Hemostatic Material Market: Company Product Application Footprint
Table 26. Biological Hemostatic Material Competitive Factors
Table 27. Biological Hemostatic Material New Entrant and Capacity Expansion Plans
Table 28. Biological Hemostatic Material Mergers & Acquisitions Activity
Table 29. United States VS China Biological Hemostatic Material Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Biological Hemostatic Material Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Biological Hemostatic Material Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Biological Hemostatic Material Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Biological Hemostatic Material Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Biological Hemostatic Material Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Biological Hemostatic Material Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Biological Hemostatic Material Production Market Share (2018-2023)
Table 37. China Based Biological Hemostatic Material Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Biological Hemostatic Material Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Biological Hemostatic Material Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Biological Hemostatic Material Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Biological Hemostatic Material Production Market Share (2018-2023)
Table 42. Rest of World Based Biological Hemostatic Material Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Biological Hemostatic Material Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Biological Hemostatic Material Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Biological Hemostatic Material Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Biological Hemostatic Material Production Market Share (2018-2023)
Table 47. World Biological Hemostatic Material Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Biological Hemostatic Material Production by Type (2018-2023) & (K Units)
Table 49. World Biological Hemostatic Material Production by Type (2024-2029) & (K Units)
Table 50. World Biological Hemostatic Material Production Value by Type (2018-2023) & (USD Million)
Table 51. World Biological Hemostatic Material Production Value by Type (2024-2029) & (USD Million)
Table 52. World Biological Hemostatic Material Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Biological Hemostatic Material Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Biological Hemostatic Material Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Biological Hemostatic Material Production by Application (2018-2023) & (K Units)
Table 56. World Biological Hemostatic Material Production by Application (2024-2029) & (K Units)
Table 57. World Biological Hemostatic Material Production Value by Application (2018-2023) & (USD Million)
Table 58. World Biological Hemostatic Material Production Value by Application (2024-2029) & (USD Million)
Table 59. World Biological Hemostatic Material Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Biological Hemostatic Material Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 62. Johnson & Johnson Major Business
Table 63. Johnson & Johnson Biological Hemostatic Material Product and Services
Table 64. Johnson & Johnson Biological Hemostatic Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Johnson & Johnson Recent Developments/Updates
Table 66. Johnson & Johnson Competitive Strengths & Weaknesses
Table 67. BD Basic Information, Manufacturing Base and Competitors
Table 68. BD Major Business
Table 69. BD Biological Hemostatic Material Product and Services
Table 70. BD Biological Hemostatic Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. BD Recent Developments/Updates
Table 72. BD Competitive Strengths & Weaknesses
Table 73. Baxter Basic Information, Manufacturing Base and Competitors
Table 74. Baxter Major Business
Table 75. Baxter Biological Hemostatic Material Product and Services
Table 76. Baxter Biological Hemostatic Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Baxter Recent Developments/Updates
Table 78. Baxter Competitive Strengths & Weaknesses
Table 79. B.Braun Basic Information, Manufacturing Base and Competitors
Table 80. B.Braun Major Business
Table 81. B.Braun Biological Hemostatic Material Product and Services
Table 82. B.Braun Biological Hemostatic Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. B.Braun Recent Developments/Updates
Table 84. B.Braun Competitive Strengths & Weaknesses
Table 85. Cura Medical Basic Information, Manufacturing Base and Competitors
Table 86. Cura Medical Major Business
Table 87. Cura Medical Biological Hemostatic Material Product and Services
Table 88. Cura Medical Biological Hemostatic Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Cura Medical Recent Developments/Updates
Table 90. Cura Medical Competitive Strengths & Weaknesses
Table 91. GELITA MEDICAL Basic Information, Manufacturing Base and Competitors
Table 92. GELITA MEDICAL Major Business
Table 93. GELITA MEDICAL Biological Hemostatic Material Product and Services
Table 94. GELITA MEDICAL Biological Hemostatic Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. GELITA MEDICAL Recent Developments/Updates
Table 96. GELITA MEDICAL Competitive Strengths & Weaknesses
Table 97. Curasan AG Basic Information, Manufacturing Base and Competitors
Table 98. Curasan AG Major Business
Table 99. Curasan AG Biological Hemostatic Material Product and Services
Table 100. Curasan AG Biological Hemostatic Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Curasan AG Recent Developments/Updates
Table 102. Curasan AG Competitive Strengths & Weaknesses
Table 103. Meril Life Sciences Basic Information, Manufacturing Base and Competitors
Table 104. Meril Life Sciences Major Business
Table 105. Meril Life Sciences Biological Hemostatic Material Product and Services
Table 106. Meril Life Sciences Biological Hemostatic Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Meril Life Sciences Recent Developments/Updates
Table 108. Meril Life Sciences Competitive Strengths & Weaknesses
Table 109. Zhonghui Shengxi Basic Information, Manufacturing Base and Competitors
Table 110. Zhonghui Shengxi Major Business
Table 111. Zhonghui Shengxi Biological Hemostatic Material Product and Services
Table 112. Zhonghui Shengxi Biological Hemostatic Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Zhonghui Shengxi Recent Developments/Updates
Table 114. Zhonghui Shengxi Competitive Strengths & Weaknesses
Table 115. Beijing Datsing Bio-tech Basic Information, Manufacturing Base and Competitors
Table 116. Beijing Datsing Bio-tech Major Business
Table 117. Beijing Datsing Bio-tech Biological Hemostatic Material Product and Services
Table 118. Beijing Datsing Bio-tech Biological Hemostatic Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Beijing Datsing Bio-tech Recent Developments/Updates
Table 120. Beijing Datsing Bio-tech Competitive Strengths & Weaknesses
Table 121. Guizhou Jin Jiu Biotech Basic Information, Manufacturing Base and Competitors
Table 122. Guizhou Jin Jiu Biotech Major Business
Table 123. Guizhou Jin Jiu Biotech Biological Hemostatic Material Product and Services
Table 124. Guizhou Jin Jiu Biotech Biological Hemostatic Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Guizhou Jin Jiu Biotech Recent Developments/Updates
Table 126. Guizhou Jin Jiu Biotech Competitive Strengths & Weaknesses
Table 127. Beijing Taikesiman Basic Information, Manufacturing Base and Competitors
Table 128. Beijing Taikesiman Major Business
Table 129. Beijing Taikesiman Biological Hemostatic Material Product and Services
Table 130. Beijing Taikesiman Biological Hemostatic Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Beijing Taikesiman Recent Developments/Updates
Table 132. Beijing Taikesiman Competitive Strengths & Weaknesses
Table 133. Foryou Medical Basic Information, Manufacturing Base and Competitors
Table 134. Foryou Medical Major Business
Table 135. Foryou Medical Biological Hemostatic Material Product and Services
Table 136. Foryou Medical Biological Hemostatic Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Foryou Medical Recent Developments/Updates
Table 138. Foryou Medical Competitive Strengths & Weaknesses
Table 139. Saikesaisi Holdings Group Basic Information, Manufacturing Base and Competitors
Table 140. Saikesaisi Holdings Group Major Business
Table 141. Saikesaisi Holdings Group Biological Hemostatic Material Product and Services
Table 142. Saikesaisi Holdings Group Biological Hemostatic Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Saikesaisi Holdings Group Recent Developments/Updates
Table 144. Saikesaisi Holdings Group Competitive Strengths & Weaknesses
Table 145. Biotemed Basic Information, Manufacturing Base and Competitors
Table 146. Biotemed Major Business
Table 147. Biotemed Biological Hemostatic Material Product and Services
Table 148. Biotemed Biological Hemostatic Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Biotemed Recent Developments/Updates
Table 150. Hangzhou Singclean Medical Products Basic Information, Manufacturing Base and Competitors
Table 151. Hangzhou Singclean Medical Products Major Business
Table 152. Hangzhou Singclean Medical Products Biological Hemostatic Material Product and Services
Table 153. Hangzhou Singclean Medical Products Biological Hemostatic Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 154. Global Key Players of Biological Hemostatic Material Upstream (Raw Materials)
Table 155. Biological Hemostatic Material Typical Customers
Table 156. Biological Hemostatic Material Typical Distributors
Table 1. World Biological Hemostatic Material Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Biological Hemostatic Material Production Value by Region (2018-2023) & (USD Million)
Table 3. World Biological Hemostatic Material Production Value by Region (2024-2029) & (USD Million)
Table 4. World Biological Hemostatic Material Production Value Market Share by Region (2018-2023)
Table 5. World Biological Hemostatic Material Production Value Market Share by Region (2024-2029)
Table 6. World Biological Hemostatic Material Production by Region (2018-2023) & (K Units)
Table 7. World Biological Hemostatic Material Production by Region (2024-2029) & (K Units)
Table 8. World Biological Hemostatic Material Production Market Share by Region (2018-2023)
Table 9. World Biological Hemostatic Material Production Market Share by Region (2024-2029)
Table 10. World Biological Hemostatic Material Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Biological Hemostatic Material Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Biological Hemostatic Material Major Market Trends
Table 13. World Biological Hemostatic Material Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Biological Hemostatic Material Consumption by Region (2018-2023) & (K Units)
Table 15. World Biological Hemostatic Material Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Biological Hemostatic Material Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Biological Hemostatic Material Producers in 2022
Table 18. World Biological Hemostatic Material Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Biological Hemostatic Material Producers in 2022
Table 20. World Biological Hemostatic Material Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Biological Hemostatic Material Company Evaluation Quadrant
Table 22. World Biological Hemostatic Material Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Biological Hemostatic Material Production Site of Key Manufacturer
Table 24. Biological Hemostatic Material Market: Company Product Type Footprint
Table 25. Biological Hemostatic Material Market: Company Product Application Footprint
Table 26. Biological Hemostatic Material Competitive Factors
Table 27. Biological Hemostatic Material New Entrant and Capacity Expansion Plans
Table 28. Biological Hemostatic Material Mergers & Acquisitions Activity
Table 29. United States VS China Biological Hemostatic Material Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Biological Hemostatic Material Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Biological Hemostatic Material Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Biological Hemostatic Material Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Biological Hemostatic Material Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Biological Hemostatic Material Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Biological Hemostatic Material Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Biological Hemostatic Material Production Market Share (2018-2023)
Table 37. China Based Biological Hemostatic Material Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Biological Hemostatic Material Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Biological Hemostatic Material Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Biological Hemostatic Material Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Biological Hemostatic Material Production Market Share (2018-2023)
Table 42. Rest of World Based Biological Hemostatic Material Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Biological Hemostatic Material Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Biological Hemostatic Material Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Biological Hemostatic Material Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Biological Hemostatic Material Production Market Share (2018-2023)
Table 47. World Biological Hemostatic Material Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Biological Hemostatic Material Production by Type (2018-2023) & (K Units)
Table 49. World Biological Hemostatic Material Production by Type (2024-2029) & (K Units)
Table 50. World Biological Hemostatic Material Production Value by Type (2018-2023) & (USD Million)
Table 51. World Biological Hemostatic Material Production Value by Type (2024-2029) & (USD Million)
Table 52. World Biological Hemostatic Material Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Biological Hemostatic Material Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Biological Hemostatic Material Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Biological Hemostatic Material Production by Application (2018-2023) & (K Units)
Table 56. World Biological Hemostatic Material Production by Application (2024-2029) & (K Units)
Table 57. World Biological Hemostatic Material Production Value by Application (2018-2023) & (USD Million)
Table 58. World Biological Hemostatic Material Production Value by Application (2024-2029) & (USD Million)
Table 59. World Biological Hemostatic Material Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Biological Hemostatic Material Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 62. Johnson & Johnson Major Business
Table 63. Johnson & Johnson Biological Hemostatic Material Product and Services
Table 64. Johnson & Johnson Biological Hemostatic Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Johnson & Johnson Recent Developments/Updates
Table 66. Johnson & Johnson Competitive Strengths & Weaknesses
Table 67. BD Basic Information, Manufacturing Base and Competitors
Table 68. BD Major Business
Table 69. BD Biological Hemostatic Material Product and Services
Table 70. BD Biological Hemostatic Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. BD Recent Developments/Updates
Table 72. BD Competitive Strengths & Weaknesses
Table 73. Baxter Basic Information, Manufacturing Base and Competitors
Table 74. Baxter Major Business
Table 75. Baxter Biological Hemostatic Material Product and Services
Table 76. Baxter Biological Hemostatic Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Baxter Recent Developments/Updates
Table 78. Baxter Competitive Strengths & Weaknesses
Table 79. B.Braun Basic Information, Manufacturing Base and Competitors
Table 80. B.Braun Major Business
Table 81. B.Braun Biological Hemostatic Material Product and Services
Table 82. B.Braun Biological Hemostatic Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. B.Braun Recent Developments/Updates
Table 84. B.Braun Competitive Strengths & Weaknesses
Table 85. Cura Medical Basic Information, Manufacturing Base and Competitors
Table 86. Cura Medical Major Business
Table 87. Cura Medical Biological Hemostatic Material Product and Services
Table 88. Cura Medical Biological Hemostatic Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Cura Medical Recent Developments/Updates
Table 90. Cura Medical Competitive Strengths & Weaknesses
Table 91. GELITA MEDICAL Basic Information, Manufacturing Base and Competitors
Table 92. GELITA MEDICAL Major Business
Table 93. GELITA MEDICAL Biological Hemostatic Material Product and Services
Table 94. GELITA MEDICAL Biological Hemostatic Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. GELITA MEDICAL Recent Developments/Updates
Table 96. GELITA MEDICAL Competitive Strengths & Weaknesses
Table 97. Curasan AG Basic Information, Manufacturing Base and Competitors
Table 98. Curasan AG Major Business
Table 99. Curasan AG Biological Hemostatic Material Product and Services
Table 100. Curasan AG Biological Hemostatic Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Curasan AG Recent Developments/Updates
Table 102. Curasan AG Competitive Strengths & Weaknesses
Table 103. Meril Life Sciences Basic Information, Manufacturing Base and Competitors
Table 104. Meril Life Sciences Major Business
Table 105. Meril Life Sciences Biological Hemostatic Material Product and Services
Table 106. Meril Life Sciences Biological Hemostatic Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Meril Life Sciences Recent Developments/Updates
Table 108. Meril Life Sciences Competitive Strengths & Weaknesses
Table 109. Zhonghui Shengxi Basic Information, Manufacturing Base and Competitors
Table 110. Zhonghui Shengxi Major Business
Table 111. Zhonghui Shengxi Biological Hemostatic Material Product and Services
Table 112. Zhonghui Shengxi Biological Hemostatic Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Zhonghui Shengxi Recent Developments/Updates
Table 114. Zhonghui Shengxi Competitive Strengths & Weaknesses
Table 115. Beijing Datsing Bio-tech Basic Information, Manufacturing Base and Competitors
Table 116. Beijing Datsing Bio-tech Major Business
Table 117. Beijing Datsing Bio-tech Biological Hemostatic Material Product and Services
Table 118. Beijing Datsing Bio-tech Biological Hemostatic Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Beijing Datsing Bio-tech Recent Developments/Updates
Table 120. Beijing Datsing Bio-tech Competitive Strengths & Weaknesses
Table 121. Guizhou Jin Jiu Biotech Basic Information, Manufacturing Base and Competitors
Table 122. Guizhou Jin Jiu Biotech Major Business
Table 123. Guizhou Jin Jiu Biotech Biological Hemostatic Material Product and Services
Table 124. Guizhou Jin Jiu Biotech Biological Hemostatic Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Guizhou Jin Jiu Biotech Recent Developments/Updates
Table 126. Guizhou Jin Jiu Biotech Competitive Strengths & Weaknesses
Table 127. Beijing Taikesiman Basic Information, Manufacturing Base and Competitors
Table 128. Beijing Taikesiman Major Business
Table 129. Beijing Taikesiman Biological Hemostatic Material Product and Services
Table 130. Beijing Taikesiman Biological Hemostatic Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Beijing Taikesiman Recent Developments/Updates
Table 132. Beijing Taikesiman Competitive Strengths & Weaknesses
Table 133. Foryou Medical Basic Information, Manufacturing Base and Competitors
Table 134. Foryou Medical Major Business
Table 135. Foryou Medical Biological Hemostatic Material Product and Services
Table 136. Foryou Medical Biological Hemostatic Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Foryou Medical Recent Developments/Updates
Table 138. Foryou Medical Competitive Strengths & Weaknesses
Table 139. Saikesaisi Holdings Group Basic Information, Manufacturing Base and Competitors
Table 140. Saikesaisi Holdings Group Major Business
Table 141. Saikesaisi Holdings Group Biological Hemostatic Material Product and Services
Table 142. Saikesaisi Holdings Group Biological Hemostatic Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Saikesaisi Holdings Group Recent Developments/Updates
Table 144. Saikesaisi Holdings Group Competitive Strengths & Weaknesses
Table 145. Biotemed Basic Information, Manufacturing Base and Competitors
Table 146. Biotemed Major Business
Table 147. Biotemed Biological Hemostatic Material Product and Services
Table 148. Biotemed Biological Hemostatic Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Biotemed Recent Developments/Updates
Table 150. Hangzhou Singclean Medical Products Basic Information, Manufacturing Base and Competitors
Table 151. Hangzhou Singclean Medical Products Major Business
Table 152. Hangzhou Singclean Medical Products Biological Hemostatic Material Product and Services
Table 153. Hangzhou Singclean Medical Products Biological Hemostatic Material Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 154. Global Key Players of Biological Hemostatic Material Upstream (Raw Materials)
Table 155. Biological Hemostatic Material Typical Customers
Table 156. Biological Hemostatic Material Typical Distributors
LIST OF FIGURES
Figure 1. Biological Hemostatic Material Picture
Figure 2. World Biological Hemostatic Material Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Biological Hemostatic Material Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Biological Hemostatic Material Production (2018-2029) & (K Units)
Figure 5. World Biological Hemostatic Material Average Price (2018-2029) & (US$/Unit)
Figure 6. World Biological Hemostatic Material Production Value Market Share by Region (2018-2029)
Figure 7. World Biological Hemostatic Material Production Market Share by Region (2018-2029)
Figure 8. North America Biological Hemostatic Material Production (2018-2029) & (K Units)
Figure 9. Europe Biological Hemostatic Material Production (2018-2029) & (K Units)
Figure 10. China Biological Hemostatic Material Production (2018-2029) & (K Units)
Figure 11. Japan Biological Hemostatic Material Production (2018-2029) & (K Units)
Figure 12. Biological Hemostatic Material Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Biological Hemostatic Material Consumption (2018-2029) & (K Units)
Figure 15. World Biological Hemostatic Material Consumption Market Share by Region (2018-2029)
Figure 16. United States Biological Hemostatic Material Consumption (2018-2029) & (K Units)
Figure 17. China Biological Hemostatic Material Consumption (2018-2029) & (K Units)
Figure 18. Europe Biological Hemostatic Material Consumption (2018-2029) & (K Units)
Figure 19. Japan Biological Hemostatic Material Consumption (2018-2029) & (K Units)
Figure 20. South Korea Biological Hemostatic Material Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Biological Hemostatic Material Consumption (2018-2029) & (K Units)
Figure 22. India Biological Hemostatic Material Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Biological Hemostatic Material by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Biological Hemostatic Material Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Biological Hemostatic Material Markets in 2022
Figure 26. United States VS China: Biological Hemostatic Material Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Biological Hemostatic Material Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Biological Hemostatic Material Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Biological Hemostatic Material Production Market Share 2022
Figure 30. China Based Manufacturers Biological Hemostatic Material Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Biological Hemostatic Material Production Market Share 2022
Figure 32. World Biological Hemostatic Material Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Biological Hemostatic Material Production Value Market Share by Type in 2022
Figure 34. Collagen
Figure 35. Gelatin
Figure 36. Polysaccharides
Figure 37. Other
Figure 38. World Biological Hemostatic Material Production Market Share by Type (2018-2029)
Figure 39. World Biological Hemostatic Material Production Value Market Share by Type (2018-2029)
Figure 40. World Biological Hemostatic Material Average Price by Type (2018-2029) & (US$/Unit)
Figure 41. World Biological Hemostatic Material Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 42. World Biological Hemostatic Material Production Value Market Share by Application in 2022
Figure 43. Hospital
Figure 44. Clinic
Figure 45. Other
Figure 46. World Biological Hemostatic Material Production Market Share by Application (2018-2029)
Figure 47. World Biological Hemostatic Material Production Value Market Share by Application (2018-2029)
Figure 48. World Biological Hemostatic Material Average Price by Application (2018-2029) & (US$/Unit)
Figure 49. Biological Hemostatic Material Industry Chain
Figure 50. Biological Hemostatic Material Procurement Model
Figure 51. Biological Hemostatic Material Sales Model
Figure 52. Biological Hemostatic Material Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
Figure 1. Biological Hemostatic Material Picture
Figure 2. World Biological Hemostatic Material Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Biological Hemostatic Material Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Biological Hemostatic Material Production (2018-2029) & (K Units)
Figure 5. World Biological Hemostatic Material Average Price (2018-2029) & (US$/Unit)
Figure 6. World Biological Hemostatic Material Production Value Market Share by Region (2018-2029)
Figure 7. World Biological Hemostatic Material Production Market Share by Region (2018-2029)
Figure 8. North America Biological Hemostatic Material Production (2018-2029) & (K Units)
Figure 9. Europe Biological Hemostatic Material Production (2018-2029) & (K Units)
Figure 10. China Biological Hemostatic Material Production (2018-2029) & (K Units)
Figure 11. Japan Biological Hemostatic Material Production (2018-2029) & (K Units)
Figure 12. Biological Hemostatic Material Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Biological Hemostatic Material Consumption (2018-2029) & (K Units)
Figure 15. World Biological Hemostatic Material Consumption Market Share by Region (2018-2029)
Figure 16. United States Biological Hemostatic Material Consumption (2018-2029) & (K Units)
Figure 17. China Biological Hemostatic Material Consumption (2018-2029) & (K Units)
Figure 18. Europe Biological Hemostatic Material Consumption (2018-2029) & (K Units)
Figure 19. Japan Biological Hemostatic Material Consumption (2018-2029) & (K Units)
Figure 20. South Korea Biological Hemostatic Material Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Biological Hemostatic Material Consumption (2018-2029) & (K Units)
Figure 22. India Biological Hemostatic Material Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Biological Hemostatic Material by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Biological Hemostatic Material Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Biological Hemostatic Material Markets in 2022
Figure 26. United States VS China: Biological Hemostatic Material Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Biological Hemostatic Material Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Biological Hemostatic Material Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Biological Hemostatic Material Production Market Share 2022
Figure 30. China Based Manufacturers Biological Hemostatic Material Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Biological Hemostatic Material Production Market Share 2022
Figure 32. World Biological Hemostatic Material Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Biological Hemostatic Material Production Value Market Share by Type in 2022
Figure 34. Collagen
Figure 35. Gelatin
Figure 36. Polysaccharides
Figure 37. Other
Figure 38. World Biological Hemostatic Material Production Market Share by Type (2018-2029)
Figure 39. World Biological Hemostatic Material Production Value Market Share by Type (2018-2029)
Figure 40. World Biological Hemostatic Material Average Price by Type (2018-2029) & (US$/Unit)
Figure 41. World Biological Hemostatic Material Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 42. World Biological Hemostatic Material Production Value Market Share by Application in 2022
Figure 43. Hospital
Figure 44. Clinic
Figure 45. Other
Figure 46. World Biological Hemostatic Material Production Market Share by Application (2018-2029)
Figure 47. World Biological Hemostatic Material Production Value Market Share by Application (2018-2029)
Figure 48. World Biological Hemostatic Material Average Price by Application (2018-2029) & (US$/Unit)
Figure 49. Biological Hemostatic Material Industry Chain
Figure 50. Biological Hemostatic Material Procurement Model
Figure 51. Biological Hemostatic Material Sales Model
Figure 52. Biological Hemostatic Material Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
